Tyler Shelton | White & Case LLP International Law Firm, Global Law Practice
Tyler Shelton
Tyler Shelton

Tyler Shelton

Associate, New York

T +1 212 819 8334

E tyler.shelton@whitecase.com


Tyler Shelton is an associate in the Mergers and Acquisitions Practice Group, and is a resident in the New York office. Mr. Shelton focuses on the representation of corporate clients, private equity funds and commercial banks in connection with domestic and global mergers, acquisitions and equity investments in a broad range of industries.

Bars and Courts

  • New York State Bar


  • JD, Southern Methodist University
  • BA, Wake Forest University


  • English


Panasonic Corporation, 2015

Representation of Panasonic Corporation in the US$1.545 billion acquisition of Hussmann Corporation, a Missouri-based manufacturer of refrigerated display cases and systems, from shareholders, including Clayton, Dubilier and Rice LLC.

Anthem, Inc., 2015

Representation of Anthem, Inc., one of the nation's largest health benefits companies, in its US$54.2 billion agreement to acquire Cigna Corporation, a combination that will create a premiere health benefits company with critical diversification and scale to lead the transformation of health care delivery for consumers.

Zimmer Holdings, Inc., 2015

Representation of Zimmer Holdings, Inc. (NYSE and SIX: ZMH), a world leader in musculoskeletal health solutions, in its US$13.35 billion acquisition of Biomet, Inc., one of the world's leading medical device manufacturers.

GFI Group sale to BGC Partners, 2014

Representation of the Special Committee of the Board of Directors of GFI Group Inc., (NYSE: GFIG), the New York brokerage and clearing house, in the successful completion of a tender offer by BGC Partners, Inc. (NASDAQ: BGCP), a leading global brokerage company servicing the financial and real estate markets, for the outstanding shares of GFI, resulting in an equity value of approximately US$780 million and an enterprise value of US$1 billion. The transaction marks one of the most complex hostile M&A transactions.